AbbVie Inc (ABBV)
163.79
+2.98
(+1.85%)
USD |
NYSE |
May 03, 16:00
163.50
-0.29
(-0.18%)
Pre-Market: 20:00
AbbVie Total Return Level: 261.73 for May 3, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 03, 2024 | 261.73 |
May 02, 2024 | 256.97 |
May 01, 2024 | 258.43 |
April 30, 2024 | 259.90 |
April 29, 2024 | 258.11 |
April 26, 2024 | 255.07 |
April 25, 2024 | 267.33 |
April 24, 2024 | 268.14 |
April 23, 2024 | 270.92 |
April 22, 2024 | 268.29 |
April 19, 2024 | 265.92 |
April 18, 2024 | 263.12 |
April 17, 2024 | 262.47 |
April 16, 2024 | 259.74 |
April 15, 2024 | 258.35 |
April 12, 2024 | 259.32 |
April 11, 2024 | 265.16 |
April 10, 2024 | 267.55 |
April 09, 2024 | 269.31 |
April 08, 2024 | 268.77 |
April 05, 2024 | 269.09 |
April 04, 2024 | 265.76 |
April 03, 2024 | 280.69 |
April 02, 2024 | 286.01 |
April 01, 2024 | 286.12 |
Date | Value |
---|---|
March 28, 2024 | 288.24 |
March 27, 2024 | 285.47 |
March 26, 2024 | 283.63 |
March 25, 2024 | 282.59 |
March 22, 2024 | 282.46 |
March 21, 2024 | 280.96 |
March 20, 2024 | 279.01 |
March 19, 2024 | 284.38 |
March 18, 2024 | 282.53 |
March 15, 2024 | 281.56 |
March 14, 2024 | 286.82 |
March 13, 2024 | 284.69 |
March 12, 2024 | 286.37 |
March 11, 2024 | 284.33 |
March 08, 2024 | 283.10 |
March 07, 2024 | 285.82 |
March 06, 2024 | 286.59 |
March 05, 2024 | 283.59 |
March 04, 2024 | 280.25 |
March 01, 2024 | 283.19 |
February 29, 2024 | 278.66 |
February 28, 2024 | 281.75 |
February 27, 2024 | 283.32 |
February 26, 2024 | 283.03 |
February 23, 2024 | 281.89 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
81.47
Minimum
Aug 15 2019
288.24
Maximum
Mar 28 2024
177.90
Average
169.42
Median
Nov 15 2021
Total Return Level Benchmarks
Amgen Inc | 432.76 |
Johnson & Johnson | 479.33 |
Eli Lilly and Co | 2115.57 |
Merck & Co Inc | 428.38 |
Pfizer Inc | 95.05 |